SEC Form D · filed October 20, 2020
A2 Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
David Goeddel · Agoura Hills, CADirectorMichael Gallo · Agoura Hills, CADirectorMadhavan Balachandran · Agoura Hills, CADirectorJakob S. Loven · Agoura Hills, CADirectorHelen S. Kim · Agoura Hills, CADirectorSrini Akkaraju · Agoura Hills, CADirectorScott Foraker · Agoura Hills, CAExec · DirectorC. A. Kamb · Agoura Hills, CADirectorLaurence Barker · London, United KingdomDirectorKate Bingham · London, United KingdomDirectorHouman Ashrafian · London, United KingdomDirectorCroatan Investment Management LLC · VIRGINIA BEACH, VADirectorJonathan Behr · London, United KingdomExec · DirectorJason Zhang · Stamford, CTDirectorCroatan All-Weather Fund II Advisers, LLC · VIRGINIA BEACH, VADirectorRalph Achacoso · Stamford, CTDirectorJames Gibson · Excelsior, MNExec · DirectorJohn Menzies · Austin, TXDirectorKevin Puil · Austin, TXDirectorJonathon Gay · BOSTON, MADirectorDaniel Gay · BOSTON, MADirectorPaul Vroomen · Santa Clara, CADirectorDaniel Armbrust · Santa Clara, CADirectorJohn Provine · Santa Clara, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗